Add BrightSurf on Google Email

Science News for June 13, 2010


How bacteria make syringes

Researchers elucidated the basic principles of bacterial transport channel assembly, a mechanism used by pathogens to deliver virulence factors. The discovery opens doors to developing anti-infective drugs that can target this process before antibiotics, offering a major advantage in infection treatment.

SourceMax-Planck-Gesellschaft·JournalNature Structural & Molecular Biology·DateJun 13, 2010

New CU-Boulder study indicates an ancient ocean may have covered one-third of Mars

A new CU-Boulder study provides further support for the idea of a sustained sea on Mars during the Noachian era, suggesting an ancient ocean likely covered about 36% of the planet. The research implies an Earth-like global hydrological cycle, including precipitation, runoff, cloud formation, and ice and groundwater accumulation.

SourceUniversity of Colorado at Boulder·JournalNature Geoscience·DateJun 13, 2010
Davis Instruments Vantage Pro2 Weather Station

Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.

Mass. General researchers develop functional, transplantable rat liver grafts

Scientists at Massachusetts General Hospital have developed a technique to grow transplantable replacement livers using the structural tissue of rat livers. The approach involves decellularizing the liver and reseeding it with liver cells, resulting in normal liver function for up to 10 days in culture.

SourceMassachusetts General Hospital·JournalNature Medicine·DateJun 13, 2010

University Hospitals Case Medical Center cardiologists discover cancer risks in blood pressure meds

Cardiologists at University Hospitals Case Medical Center have discovered a significant association between angiotensin-receptor blockers (ARBs) and an increased risk of new cancers. The meta-analysis found that patients taking ARBs had a 8-11% higher risk of developing new cancer compared to those taking control medications.

SourceUniversity Hospitals Cleveland Medical Center·JournalThe Lancet Oncology·DateJun 13, 2010

Widely used class of blood pressure medications linked to increased cancer risk

A meta-analysis of publicly available data from randomised trials found that patients taking ARBs had a significantly increased likelihood of new cancer diagnosis compared with patients in control groups. The study also found a modestly increased risk of lung cancer among ARB users, but no significant excess in cancer deaths.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJun 13, 2010

Should the results of individual genetic studies be disclosed to participants?

Researchers generally agree that genetic variation findings should be shared with participants if clinically significant, but confidence levels vary across disciplines and conditions. The study highlights the complexity of this issue, suggesting that factors beyond scientific robustness influence researchers' decisions on disclosure.

SourceEuropean Society of Human Genetics·DateJun 13, 2010
GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.